Relative Bioavailability of a Single Oral Dose of BI 894416 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, One-way Crossover Study)
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2019
Price : $35 *
At a glance
- Drugs BI 894416 (Primary) ; Itraconazole
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 09 Jan 2019 Status changed from recruiting to completed.
- 16 Nov 2018 Status changed from not yet recruiting to recruiting.
- 02 Nov 2018 New trial record